PURPLE BIOTECH LTD SPONSORED ADR - ADR (PPBT)

CUSIP: 74638P109

Q4 2024 13F Holders as of 31 Dec 2024

Share change
0
SEC-reported price per share
$4.67
Indexed holders
1

Security key

74638P109

Report period

Q4 2024

Indexed institutions

1

Top holders

1

Ownership snapshot

Top reported holders of PPBT - PURPLE BIOTECH LTD SPONSORED ADR - ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/11
Latest evidence
30 Sep 2024
13F Highest disclosed value: $876,900 11 rows are not safely comparable across share classes. Showing 1-6 of 11 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $876.9K.

0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
ARMISTICE CAPITAL, LLC $876.9K
MORGAN STANLEY $44.7K
BNP PARIBAS FINANCIAL MARKETS $20.4K
Tower Research Capital LLC (TRC) $1.4K
TD Waterhouse Canada Inc. $1.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 11 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$876,900
158,000 shares
— 30 Sep 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$44,706
8,055 shares
— 30 Sep 2024
BNP PARIBAS FINANCIAL MARKETS
13F
Company
13F
—
denominator unverified
$20,396
3,675 shares
— 30 Sep 2024
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$1,415
254 shares
— 30 Sep 2024
TD Waterhouse Canada Inc.
13F
Company
13F
—
denominator unverified
$1,141
200 shares
— 30 Sep 2024
ROYAL BANK OF CANADA
13F
Company
13F
—
denominator unverified
$1,000
107 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
1
Shares
15
Indexed holders
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 indexed holders
1
Q4 2024 indexed holders
1
Indexed holder difference
0
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .